Review of Canine Lymphoma Treated with Chemotherapy—Outcomes and Prognostic Factors
While canine lymphoma is a relatively common and important disease seen by veterinarians, there are limited comprehensive reviews of the literature regarding the remission and survival times following chemotherapy, and the associated prognostic factors. This comprehensive thematic review covers the...
Main Authors: | Peter Bennett, Peter Williamson, Rosanne Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/10/5/342 |
Similar Items
-
Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma
by: Stefanie Limmer, et al.
Published: (2022-12-01) -
Evaluation of factors influencing survival time in 77 dogs with lymphoma
by: Soo-Yeon Jeong
Published: (2023-09-01) -
Canine Multicentric Lymphoma: Diagnostic, Treatment, and Prognostic Insights
by: Michelle do Carmo Pereira Rocha, et al.
Published: (2025-01-01) -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
by: Annarosa Cuccaro, et al.
Published: (2014-07-01) -
Clinical Outcome of Multicentric Lymphoma Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone (CHOP) in Small Breed Dogs
by: Tae-Hee Kim, et al.
Published: (2024-10-01)